Key result
Recurrent diffuse large B-cell lymphoma developed on a second aortic valve allograft within one year, indicating an aggressive clinical course that may require early systemic chemotherapy.
Case Report (n=1)
No
This first report of recurrent diffuse large B-cell lymphoma on an aortic valve allograft highlights the aggressive nature of the tumor and suggests a potential role for early systemic chemotherapy alongside surgical resection.
Answers are grounded in this paper and cite their sources.
Raises awareness for lymphoma recurrence on valve allografts; leaves open optimal chemotherapy timing in this rare presentation.
Primary malignant cardiac lymphomas associated with grafts are extremely rare: to our knowledge, only 6 cases of prosthesis-associated B-cell lymphoma have been reported. Ours is the first report of recurrent diffuse large B-cell lymphoma associated with aortic valve allografts. We treated a 60-year-old man who presented in early 2007 with aortic valve endocarditis. He underwent aortic valve replacement with an allograft; the resected native valve showed active endocarditis without tumor. In January 2011, the patient underwent repeat aortic valve replacement because of symptomatic aortic regurgitation. The explanted valve specimen displayed diffuse large B-cell lymphoma. In September 2011, the patient presented with fever and a mass around the aortic valve. He died in January 2012. On autopsy, the explanted replacement valve displayed recurrent diffuse large B-cell lymphoma. The recurrent lymphoma on a new graft leads us to believe that this tumor is more aggressive than had been thought. We propose early systemic chemotherapy, in addition to tumor resection, for the possibility of a better prognosis. We discuss our patient's case and review the relevant medical literature.
No takes yet. Share an insight, caveat, or question.
Farah et al. (2014) conducted a case report in Primary Cardiac Lymphoma on Aortic Valve Allograft (n=1). Aortic valve allograft was evaluated on Recurrence of diffuse large B-cell lymphoma. Recurrent diffuse large B-cell lymphoma developed on a second aortic valve allograft within one year, indicating an aggressive clinical course that may require early systemic chemotherapy.
Synapse has enriched 10 related papers. Consider them for comparative context: